18 minutes ago, Frank Pembleton said:

Vidim par nekih poznanika iz CG koji su bili ono u fazonu "doneli nam iz Srbije coronu", sada kače slike na FB kako se astrozekuju ovde...

.... Shiit has hit the fan!
 

ovaj poklonik porazenih snaga doslovce je opet slagao. vakcine iz srbije su dosle a i tih 5000 ruskih " samo sto nisu" su dosle 26. februara. 

ocekuju se sledece srede i 30000 kineskih.

situacija jeste dramaticna ali je logican sled nekompetentnosti dps kadrova koji su okretali glave na razna patriotska okupljanja. 

druga stvar dps vlada je sve cinila da se vakcine ne nabave. nisu platili nekakvu vrstu kotizacije da bi crna gora stala u red za vakcine. nisu narucivali vakcine. ama bas nista nisu uradili po tom pitanju. samo su objavili da poznati milov gangster i perac para petros statis nudi 10000 vakcina preko njegovih "poslovnih" veza. 

naravno da je to odbijeno jer prava ponuda nije ni postojala. 

 

 

 

1 hour ago, Niveamen said:

Koliko je dana proslo od kad si se zarazio? Moja komsinica (1958)se zarazila i bila je skroz ok,nije mirovala,setkala se,itd.. da bi 13 dana od zarazavanja pala u krevet i zaglavaila Arenu na kiseoniku mesec dana.Evo je i dan danas ne moze da se oporavi,seta vrlo malo,al vidi se da to nije ista zena i da nikad nece biti ona stara.

 

Nisam zarazen daleko bilo

Quote

 

Vaccinating the oldest against COVID-19 saves both the most lives and most years of life

Many competing criteria are under consideration for prioritizing COVID-19 vaccination. Two criteria based on age are demographic: lives saved and years of future life saved. Vaccinating the very old against COVID-19 saves the most lives, but, since older age is accompanied by falling life expectancy, it is widely supposed that these two goals are in conflict. We show this to be mistaken. The age patterns of COVID-19 mortality are such that vaccinating the oldest first saves the most lives and, surprisingly, also maximizes years of remaining life expectancy. We demonstrate this relationship empirically in the United States, Germany, and South Korea and with mathematical analysis of life tables. Our age-risk results, under usual conditions, also apply to health risks.

 

https://www.pnas.org/content/118/11/e2026322118

Izvinjavam se ako je neko kačio već, ali ovo je baš informativno i pregledno, brošura Farmaceutskog fakulteta o vakcinama...

 

http://www.pharmacy.bg.ac.rs/files/Obavestenja/2021/Brosura vakcine/Brosura vakcina_final.pdf

Quote

Prognosis

J&J Shot to Get EU Nod in Early March, Easing Supply Squeeze

By Nikos Chrysoloras and Morten Buttler

February 26, 2021, 5:16 AM EST Updated on February 26, 2021, 8:07 AM EST

- Bloc’s medicines regulator is said to plan March 11 opinion
- Supply surge puts onus on governments to administer vaccines

The European Union’s medicines regulator is set to recommend Johnson & Johnson’s coronavirus vaccine early next month, bolstering supplies even as governments struggle to get shots into people’s arms.

The European Medicines Agency’s nod is expected on March 11, an EU official said on condition of anonymity. It would clear the way for market authorization of a fourth Covid-19 vaccine, alongside those from Moderna Inc., AstraZeneca Plc and a partnership of Pfizer Inc. and BioNTech SE.

An EMA spokesperson said the agency is working toward issuing an opinion by mid-March but it couldn’t confirm a date. The EU official also said EMA talks are ongoing with Russian authorities on the Sputnik V vaccine and may receive data soon to begin a rolling review process.

The European Commission has said deliveries of the J&J shot are expected to begin in early April, adding to a surge in supplies over the second and third quarter. President Ursula von der Leyen showed a slide to EU leaders during a video summit Thursday projecting a dramatic increase in vaccine deliveries over the coming months.

While some leaders, including Italian Prime Minister Mario Draghi, have said they aren’t convinced about the reliability of such forecasts, independent analysis from London-based research firm Airfinity Ltd. shows that EU supplies should suffice to vaccinate 75% of the region’s adult population by the end of August.

The EU’s advance purchase deal with J&J allows member to purchase vaccines for 200 million people, with an option for another 200 million. The EMA is also carrying out a rolling review of the CureVac NV and Novavax Inc. shots. The Commission has struck deals for the initial purchase of 225 million CureVac shots and concluded exploratory talks with Novavax to purchase 100 million doses.

The increase in deliveries puts the onus on EU governments to speed up inoculations. Governments have attributed the underwhelming rollout to delays in the procurement of shots, which has been managed by the commission, and the EMA’s slow approval process.

In the U.S., a committee of advisers to the Food and Drug Administration is meeting to review J&J’s shot on Friday.

Data shown by Von der Leyen to leaders illustrate that more than 20 million shots delivered to the EU’s 27 member states have yet to be administered, raising doubts about the national health authorities’ ability to handle the looming supply surge and mobilize the resources needed to ramp up vaccinations.

Questions around the efficacy of the shot from AstraZeneca and its partner, the University of Oxford, and restrictions on its use among the elderly in many EU countries have fueled skepticism. Vast stocks of the vaccine have been left unused in France and Germany.

Trailing the U.S., U.K.
The EU lags behind the U.S. and the U.K. in its inoculation campaign, having delivered just 6.8 doses per 100 people, according to Bloomberg’s global tracker. But performance varies between member states, with Denmark delivering about four times as many doses as Bulgaria per 100 people, even though each government has access to the same number of shots relative to its population.

Although about 33% of all vaccines delivered to the EU have gone unused, Denmark is using every drop available. It’s also aiming to immunize all adults by the end of June, faster than the EU-wide target of Sept. 21.

If other countries are leaving unused vials, Denmark is happy to purchase more, Prime Minister Mette Frederiksen said.

“We will very much like to bring them to Denmark,” Frederiksen told reporters in Copenhagen on Friday. “And we will also pay a good price for the vaccines.”

 

https://www.bloomberg.com/news/articles/2021-02-26/j-j-shot-set-to-get-eu-nod-in-early-march-easing-supply-squeeze?srnd=premium&sref=WJKVI5nK

Edited February 28, 20214 yr by vememah

Quote

 

Novavax Inc expects data from a late-stage U.S. trial of its COVID-19 vaccine at the start of April, after which it will apply for emergency use authorization, the drug developer’s R&D head Gregory Glenn said on Wednesday.

“We are expecting results right in the beginning of quarter two and shortly thereafter we will be filing for EUA (in U.S.),” he said at a Washington Post online event.

 

https://www.reuters.com/article/us-health-coronavirus-novavax-vaccine/novavax-expects-u-s-trial-data-for-covid-19-vaccine-at-start-of-april-idINKBN2AO2HC

Quote

Single dose of Pfizer BioNTech vaccine reduces asymptomatic infections and potential for SARS-CoV-2 transmission

New data from Addenbrooke's Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by 75% the number of asymptomatic SARS-CoV-2 infections. This implies that the vaccine could significantly reduce the risk of transmission of the virus from people who are asymptomatic, as well as protecting others from getting ill...
The study, which is yet to be peer-reviewed, found that 26 out of 3,252 (0·80%) tests from unvaccinated healthcare workers were positive. This compared to 13 out of 3,535 (0.37%) tests from healthcare workers less than 12 days post-vaccination and 4 out of 1,989 (0·20%) tests from healthcare workers at 12 days or more post-vaccination.

This suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days (75 per cent protection). The level of asymptomatic infection was also halved in those vaccinated for less than 12 days.

Dr Mike Weekes, an infectious disease specialist at CUH and the University of Cambridge’s Department of Medicine, who led the study, said:  “This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2 but also helps prevent infection, reducing the potential for the virus to be passed on to others...
When the team included symptomatic healthcare workers, their analyses showed similar reductions. 56 out of 3,282 (1·71%) unvaccinated healthcare workers tested positive. This compared to 8 out of 1,997 (0·40%) healthcare workers at 12 or more days post-vaccination, a 4·3-fold reduction.

https://www.cam.ac.uk/research/news/single-dose-of-pfizer-biontech-vaccine-reduces-asymptomatic-infections-and-potential-for-sars-cov-2

Edited February 28, 20214 yr by vememah

Meni je potpuno nerealno sto US trazi sva P3 ispitivanja kad recimo za AZ imaju 10+ milona vakcinisanih staraca uz taj cuveni smuceni UK/Brazil trial.

Isto tako za NVAX cekati US rezultate a perfektna studija iz UK ce biti odobrena za koju nedjelju u Britaniji.

Britanci su potpuno izdominirali kad je primjena vakcina u pitanju

Britanci su potpuno izdominirali kad je primjena vakcina u pitanju

U petak je bilo 19.6m prve doze, znaci sad prebacili 20m.


Sent from my iPhone using Tapatalk

Javljaju da stize veceras 100k rusa. 

Sutra 58k fajzera,  i u petak 500k kineza.  

Valjda ima jos AZ.  

Nadam se da ce se svi koji zele vaakcinisati uskoro

Edited February 28, 20214 yr by Sandradjer

Imam danas neke manje posledice reakcije na vakcinu - osećaj kao da ću da se razbolim i dobijem temperaturu, a i boli me glava, ali ništa neizdrživo.

Javljaju da stize veceras 100k rusa. 
Sutra 58k fajzera,  i u petak 500k kineza.  
Valjda ima jos AZ.  
Nadam se da ce se svi koji zele vaakcinisati uskoro [emoji4]

Ajde više...

.... Shiit has hit the fan!

stigao poziv za sutra, wohoo!

 

zanimljivo mi što mi je na kraju zakazano za BelExpo

Iz koje opstine te salju u Belexpo? 

Prva koju sam stavila je bio Savski Venac, posle promenila na Stari grad.